AQR Capital Management LLC Boosts Stake in UiPath Inc. (NYSE:PATH)

AQR Capital Management LLC increased its position in shares of UiPath Inc. (NYSE:PATH) by 120.6% during the second quarter, HoldingsChannel reports. The institutional investor owned 1,633,393 shares of the healthcare company’s stock after buying an additional 892,845 shares during the quarter. AQR Capital Management LLC’s holdings in UiPath were worth $20,385,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors also recently added to or reduced their stakes in PATH. Vanguard Group Inc. raised its holdings in shares of UiPath by 5.6% in the first quarter. Vanguard Group Inc. now owns 40,217,936 shares of the healthcare company’s stock valued at $911,741,000 after buying an additional 2,133,078 shares during the last quarter. State Board of Administration of Florida Retirement System increased its position in UiPath by 0.5% in the 1st quarter. State Board of Administration of Florida Retirement System now owns 295,370 shares of the healthcare company’s stock valued at $6,696,000 after acquiring an additional 1,571 shares during the period. Benjamin F. Edwards & Company Inc. raised its stake in UiPath by 3,389.4% during the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 89,189 shares of the healthcare company’s stock valued at $1,131,000 after acquiring an additional 86,633 shares during the last quarter. Mitsubishi UFJ Trust & Banking Corp lifted its position in UiPath by 4.2% during the 1st quarter. Mitsubishi UFJ Trust & Banking Corp now owns 231,694 shares of the healthcare company’s stock worth $5,240,000 after acquiring an additional 9,393 shares during the period. Finally, Acadian Asset Management LLC grew its stake in shares of UiPath by 245.1% in the 1st quarter. Acadian Asset Management LLC now owns 45,700 shares of the healthcare company’s stock valued at $1,032,000 after purchasing an additional 32,456 shares during the last quarter. Institutional investors and hedge funds own 62.50% of the company’s stock.

Insider Transactions at UiPath

In related news, CFO Ashim Gupta sold 47,671 shares of the company’s stock in a transaction that occurred on Friday, September 13th. The stock was sold at an average price of $12.07, for a total value of $575,388.97. Following the sale, the chief financial officer now owns 849,917 shares of the company’s stock, valued at approximately $10,258,498.19. The transaction was disclosed in a filing with the SEC, which is available through this link. Corporate insiders own 22.37% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts recently weighed in on PATH shares. TD Cowen decreased their price target on UiPath from $17.00 to $16.00 and set a “hold” rating for the company in a report on Friday, September 6th. BMO Capital Markets raised their target price on shares of UiPath from $14.00 to $15.00 and gave the stock a “market perform” rating in a research note on Friday, September 6th. DA Davidson boosted their price target on shares of UiPath from $13.00 to $15.00 and gave the stock a “neutral” rating in a research note on Friday, September 6th. Barclays raised their price objective on shares of UiPath from $14.00 to $15.00 and gave the company an “equal weight” rating in a research report on Friday, September 6th. Finally, Evercore ISI lifted their price objective on UiPath from $13.00 to $16.00 and gave the company an “in-line” rating in a report on Friday, September 6th. Sixteen research analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $17.71.

UiPath Stock Performance

UiPath stock opened at $12.79 on Tuesday. The firm has a market capitalization of $7.33 billion, a price-to-earnings ratio of -79.94 and a beta of 0.87. UiPath Inc. has a fifty-two week low of $10.37 and a fifty-two week high of $27.87. The stock’s fifty day moving average is $12.17 and its two-hundred day moving average is $15.36.

UiPath (NYSE:PATH) last issued its quarterly earnings data on Thursday, September 5th. The healthcare company reported $0.04 EPS for the quarter, beating analysts’ consensus estimates of $0.03 by $0.01. The firm had revenue of $316.00 million for the quarter, compared to analysts’ expectations of $303.69 million. UiPath had a negative net margin of 8.13% and a negative return on equity of 3.98%. The firm’s revenue was up 10.0% on a year-over-year basis. During the same period in the prior year, the company earned ($0.09) EPS. As a group, sell-side analysts forecast that UiPath Inc. will post -0.23 EPS for the current fiscal year.

UiPath Company Profile

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.